Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1943 1
1946 1
1948 1
1952 1
1953 1
1954 1
1959 2
1961 1
1962 1
1963 4
1965 1
1966 1
1967 1
1968 1
1969 5
1970 2
1971 1
1972 5
1973 1
1974 3
1975 3
1976 7
1977 4
1978 4
1979 3
1980 2
1981 5
1982 12
1983 10
1984 9
1985 8
1986 14
1987 21
1988 22
1989 18
1990 15
1991 10
1992 15
1993 14
1994 10
1995 5
1996 12
1997 8
1998 8
1999 9
2000 14
2001 18
2002 17
2003 29
2004 17
2005 30
2006 28
2007 26
2008 19
2009 21
2010 26
2011 37
2012 33
2013 34
2014 33
2015 41
2016 28
2017 42
2018 29
2019 36
2020 36
2021 22
2022 37
2023 35
2024 41
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

974 results

Results by year

Filters applied: . Clear all
Page 1
Parkinson's Disease.
Tanner CM, Ostrem JL. Tanner CM, et al. N Engl J Med. 2024 Aug 1;391(5):442-452. doi: 10.1056/NEJMra2401857. N Engl J Med. 2024. PMID: 39083773 Review. No abstract available.
The epidemiology of Parkinson's disease.
Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. Ben-Shlomo Y, et al. Among authors: tanner c. Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8. Lancet. 2024. PMID: 38245248 Free PMC article. Review.
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K. Simuni T, et al. Among authors: tanner cm. Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2. Lancet Neurol. 2024. PMID: 38267190 Review.
Epidemiology of Parkinson's Disease: An Update.
Deliz JR, Tanner CM, Gonzalez-Latapi P. Deliz JR, et al. Among authors: tanner cm. Curr Neurol Neurosci Rep. 2024 Jun;24(6):163-179. doi: 10.1007/s11910-024-01339-w. Epub 2024 Apr 20. Curr Neurol Neurosci Rep. 2024. PMID: 38642225 Review.
Parkinson's Disease. Reply.
Tanner CM, Ostrem JL. Tanner CM, et al. N Engl J Med. 2024 Oct 24;391(16):1559. doi: 10.1056/NEJMc2410843. N Engl J Med. 2024. PMID: 39442056 No abstract available.
Trial of Cinpanemab in Early Parkinson's Disease.
Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T; SPARK Investigators. Lang AE, et al. Among authors: tanner cm. N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395. N Engl J Med. 2022. PMID: 35921450 Clinical Trial.
Levodopa and the progression of Parkinson's disease.
Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K; Parkinson Study Group. Fahn S, et al. Among authors: tanner c. N Engl J Med. 2004 Dec 9;351(24):2498-508. doi: 10.1056/NEJMoa033447. N Engl J Med. 2004. PMID: 15590952 Free article. Clinical Trial.
974 results